Clinical Trial Update: Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated autologous mesenchymal stem cells for idiopathic pulmonary fibrosis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED